Failure of metyrapone to inhibit 11-hydroxylation of 11-deoxycortisol during drug therapy.
D015065:17-Hydroxycorticosteroids / Q000378:metabolism*; D000311:Adrenal Glands / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000502:physiology; D002854:Chromatography, Paper; D002855:Chromatography, Thin Layer; D003480:Cushing Syndrome / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D008797:Metyrapone; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use*; D010901:Pituitary Function Tests; D012636:Secretory Rate; D013256:Steroids / Q000652:urine
D015065:17-Hydroxycorticosteroids; D013256:Steroids; D010672:Phenytoin; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone; D010634:Phenobarbital; D008797:Metyrapone